ATM and Miyoshi myopathy: Valuable data to include MM in the spectrum of cancers associated with ATM mutations were also obtained when tissue samples from fourteen MM patients with germline heterozygous ATM variants classified as pathogenic or variants of uncertain significance were investigated.